STEROID : in silico heuristic target combination identification for disease-related signaling networks

Given a signaling network, the target combination identification problem aims to predict efficacious and safe target combinations for treatment of a disease. State-of-the-art in silico methods use Monte Carlo simulated annealing (mcsa) to modify a candidate solution stochastically, and use the Metro...

Full description

Saved in:
Bibliographic Details
Main Authors: Bhowmick, Sourav S., Chua, Huey-Eng, Tucker-Kellogg, Lisa, Dewey Jr., C. Forbes
Other Authors: School of Computer Engineering
Format: Conference or Workshop Item
Language:English
Published: 2013
Subjects:
Online Access:https://hdl.handle.net/10356/96343
http://hdl.handle.net/10220/11924
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: Nanyang Technological University
Language: English
id sg-ntu-dr.10356-96343
record_format dspace
spelling sg-ntu-dr.10356-963432020-05-28T07:19:15Z STEROID : in silico heuristic target combination identification for disease-related signaling networks Bhowmick, Sourav S. Chua, Huey-Eng Tucker-Kellogg, Lisa Dewey Jr., C. Forbes School of Computer Engineering Conference on Bioinformatics, Computational Biology and Biomedicine (2012 : Orlando, USA) Singapore-MIT Alliance Programme DRNTU::Engineering::Computer science and engineering Given a signaling network, the target combination identification problem aims to predict efficacious and safe target combinations for treatment of a disease. State-of-the-art in silico methods use Monte Carlo simulated annealing (mcsa) to modify a candidate solution stochastically, and use the Metropolis criterion to accept or reject the proposed modifications. However, such stochastic modifications ignore the impact of the choice of targets and their activities on the combination's therapeutic effect and off-target effects which directly affect the solution quality. In this paper, we present Steroid, a novel method that addresses this limitation by leveraging two additional heuristic criteria to minimize off-target effects and achieve synergy for candidate modification. Specifically, off-target effects measure the unintended response of a signaling network to the target combination and is generally associated with toxicity. Synergy occurs when a pair of targets exerts effects that are greater than the sum of their individual effects, and is generally a beneficial strategy for maximizing effect while minimizing toxicity. Our empirical study on the cancer-related mapk-pi3k network demonstrates the superiority of Steroid in comparison to mcsa-based approaches. Specifically, Steroid is an order of magnitude faster and yet yields biologically relevant synergistic target combinations with significantly lower off-target effects. 2013-07-22T02:55:44Z 2019-12-06T19:29:18Z 2013-07-22T02:55:44Z 2019-12-06T19:29:18Z 2012 2012 Conference Paper Chua, H. E., Bhowmick, S. S., Tucker-Kellogg, L., & Dewey Jr., C. F. (2012). STEROID: in silico heuristic target combination identification for disease-related signaling networks. Proceedings of the ACM Conference on Bioinformatics, Computational Biology and Biomedicine - BCB '12. https://hdl.handle.net/10356/96343 http://hdl.handle.net/10220/11924 10.1145/2382936.2382937 en © 2012 ACM.
institution Nanyang Technological University
building NTU Library
country Singapore
collection DR-NTU
language English
topic DRNTU::Engineering::Computer science and engineering
spellingShingle DRNTU::Engineering::Computer science and engineering
Bhowmick, Sourav S.
Chua, Huey-Eng
Tucker-Kellogg, Lisa
Dewey Jr., C. Forbes
STEROID : in silico heuristic target combination identification for disease-related signaling networks
description Given a signaling network, the target combination identification problem aims to predict efficacious and safe target combinations for treatment of a disease. State-of-the-art in silico methods use Monte Carlo simulated annealing (mcsa) to modify a candidate solution stochastically, and use the Metropolis criterion to accept or reject the proposed modifications. However, such stochastic modifications ignore the impact of the choice of targets and their activities on the combination's therapeutic effect and off-target effects which directly affect the solution quality. In this paper, we present Steroid, a novel method that addresses this limitation by leveraging two additional heuristic criteria to minimize off-target effects and achieve synergy for candidate modification. Specifically, off-target effects measure the unintended response of a signaling network to the target combination and is generally associated with toxicity. Synergy occurs when a pair of targets exerts effects that are greater than the sum of their individual effects, and is generally a beneficial strategy for maximizing effect while minimizing toxicity. Our empirical study on the cancer-related mapk-pi3k network demonstrates the superiority of Steroid in comparison to mcsa-based approaches. Specifically, Steroid is an order of magnitude faster and yet yields biologically relevant synergistic target combinations with significantly lower off-target effects.
author2 School of Computer Engineering
author_facet School of Computer Engineering
Bhowmick, Sourav S.
Chua, Huey-Eng
Tucker-Kellogg, Lisa
Dewey Jr., C. Forbes
format Conference or Workshop Item
author Bhowmick, Sourav S.
Chua, Huey-Eng
Tucker-Kellogg, Lisa
Dewey Jr., C. Forbes
author_sort Bhowmick, Sourav S.
title STEROID : in silico heuristic target combination identification for disease-related signaling networks
title_short STEROID : in silico heuristic target combination identification for disease-related signaling networks
title_full STEROID : in silico heuristic target combination identification for disease-related signaling networks
title_fullStr STEROID : in silico heuristic target combination identification for disease-related signaling networks
title_full_unstemmed STEROID : in silico heuristic target combination identification for disease-related signaling networks
title_sort steroid : in silico heuristic target combination identification for disease-related signaling networks
publishDate 2013
url https://hdl.handle.net/10356/96343
http://hdl.handle.net/10220/11924
_version_ 1681059395647045632